Related Experiment Videos
The Rosette inhibition test in skin-grafted patients
British Medical Journal
|June 22, 1974
Summary
The rosette inhibition test did not show changes in antihuman lymphocyte globulin concentration correlating with skin graft rejection in burn patients. This suggests the test may not be a reliable indicator for monitoring graft survival post-burn injury.
Area of Science:
- Immunology
- Transplantation Science
- Burn Medicine
Background:
- Allogeneic skin grafts are crucial for treating severe burn injuries.
- Monitoring graft rejection is vital for patient outcomes.
- The rosette inhibition test is a potential method for assessing immune responses to grafts.
Purpose of the Study:
- To evaluate the utility of the rosette inhibition test in predicting allogeneic skin graft rejection.
- To determine if changes in minimal inhibitory concentration correlate with graft survival in burn patients.
Main Methods:
- Lymphocytes were collected from five patients post-allogeneic skin grafting.
- Serial rosette inhibition tests were performed.
- Minimal inhibitory concentration of antihuman lymphocyte globulin was measured to inhibit 25% rosette formation.
Main Results:
- No significant change in the minimal inhibitory concentration of antihuman lymphocyte globulin was observed.
- The observed concentrations did not specifically correlate with skin graft rejection events.
Conclusions:
- The rosette inhibition test, as applied, did not demonstrate a specific association with allogeneic skin graft rejection in severe burn patients.
- Further research may be needed to explore alternative immunological markers or refine the rosette inhibition test for this clinical context.